scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials.

TL;DR: Current controlled data suggest that use of a dexmedetomidine- or propofol-based sedation regimen rather than a benzodiazepine- based sedative regimen in critically ill adults may reduce ICU length of stay and duration of mechanical ventilation.
Abstract: Background:Use of dexmedetomidine or propofol rather than a benzodiazepine sedation strategy may improve ICU outcomes. We reviewed randomized trials comparing a benzodiazepine and nonbenzodiazepine regimen in mechanically ventilated adult ICU patients to determine if differences exist between these
Citations
More filters
Journal ArticleDOI
TL;DR: Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for these critically ill patients with high mortality.
Abstract: To provide an update to “Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012”. A consensus committee of 55 international experts representing 25 international organizations was convened. Nominal groups were assembled at key international meetings (for those committee members attending the conference). A formal conflict-of-interest (COI) policy was developed at the onset of the process and enforced throughout. A stand-alone meeting was held for all panel members in December 2015. Teleconferences and electronic-based discussion among subgroups and among the entire committee served as an integral part of the development. The panel consisted of five sections: hemodynamics, infection, adjunctive therapies, metabolic, and ventilation. Population, intervention, comparison, and outcomes (PICO) questions were reviewed and updated as needed, and evidence profiles were generated. Each subgroup generated a list of questions, searched for best available evidence, and then followed the principles of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system to assess the quality of evidence from high to very low, and to formulate recommendations as strong or weak, or best practice statement when applicable. The Surviving Sepsis Guideline panel provided 93 statements on early management and resuscitation of patients with sepsis or septic shock. Overall, 32 were strong recommendations, 39 were weak recommendations, and 18 were best-practice statements. No recommendation was provided for four questions. Substantial agreement exists among a large cohort of international experts regarding many strong recommendations for the best care of patients with sepsis. Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for these critically ill patients with high mortality.

4,303 citations

Journal ArticleDOI
TL;DR: A consensus committee of 55 international experts representing 25 international organizations was assembled at key international meetings (forSurviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012 as discussed by the authors ).
Abstract: Objective:To provide an update to “Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012.”Design:A consensus committee of 55 international experts representing 25 international organizations was convened. Nominal groups were assembled at key international meetings (for

2,414 citations

Journal ArticleDOI
03 Jun 2015-BMJ
TL;DR: Nearly a third of patients admitted to an intensive care unit develop delirium, and these patients are at increased risk of dying during admission, longer stays in hospital, and cognitive impairment after discharge.
Abstract: Objectives To determine the relation between delirium in critically ill patients and their outcomes in the short term (in the intensive care unit and in hospital) and after discharge from hospital. Design Systematic review and meta-analysis of published studies. Data sources PubMed, Embase, CINAHL, Cochrane Library, and PsychINFO, with no language restrictions, up to 1 January 2015. Eligibility criteria for selection studies Reports were eligible for inclusion if they were prospective observational cohorts or clinical trials of adults in intensive care units who were assessed with a validated delirium screening or rating system, and if the association was measured between delirium and at least one of four clinical endpoints (death during admission, length of stay, duration of mechanical ventilation, and any outcome after hospital discharge). Studies were excluded if they primarily enrolled patients with a neurological disorder or patients admitted to intensive care after cardiac surgery or organ/tissue transplantation, or centered on sedation management or alcohol or substance withdrawal. Data were extracted on characteristics of studies, populations sampled, identification of delirium, and outcomes. Random effects models and meta-regression analyses were used to pool data from individual studies. Results Delirium was identified in 5280 of 16 595 (31.8%) critically ill patients reported in 42 studies. When compared with control patients without delirium, patients with delirium had significantly higher mortality during admission (risk ratio 2.19, 94% confidence interval 1.78 to 2.70; P Conclusions Nearly a third of patients admitted to an intensive care unit develop delirium, and these patients are at increased risk of dying during admission, longer stays in hospital, and cognitive impairment after discharge.

664 citations

Journal ArticleDOI
23 May 2016-BMJ
TL;DR: Outcomes in sepsis have greatly improved overall, probably because of an enhanced focus on early diagnosis and fluid resuscitation, the rapid delivery of effective antibiotics, and other improvements in supportive care for critically ill patients.
Abstract: Sepsis, severe sepsis, and septic shock represent increasingly severe systemic inflammatory responses to infection. Sepsis is common in the aging population, and it disproportionately affects patients with cancer and underlying immunosuppression. In its most severe form, sepsis causes multiple organ dysfunction that can produce a state of chronic critical illness characterized by severe immune dysfunction and catabolism. Much has been learnt about the pathogenesis of sepsis at the molecular, cell, and intact organ level. Despite uncertainties in hemodynamic management and several treatments that have failed in clinical trials, investigational therapies increasingly target sepsis induced organ and immune dysfunction. Outcomes in sepsis have greatly improved overall, probably because of an enhanced focus on early diagnosis and fluid resuscitation, the rapid delivery of effective antibiotics, and other improvements in supportive care for critically ill patients. These improvements include lung protective ventilation, more judicious use of blood products, and strategies to reduce nosocomial infections.

663 citations

References
More filters
Journal ArticleDOI
TL;DR: This paper examines eight published reviews each reporting results from several related trials in order to evaluate the efficacy of a certain treatment for a specified medical condition and suggests a simple noniterative procedure for characterizing the distribution of treatment effects in a series of studies.

33,234 citations

Journal ArticleDOI
18 Oct 2011-BMJ
TL;DR: The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate.
Abstract: Flaws in the design, conduct, analysis, and reporting of randomised trials can cause the effect of an intervention to be underestimated or overestimated. The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate

22,227 citations

Journal ArticleDOI
TL;DR: The form and validation results of APACHE II, a severity of disease classification system that uses a point score based upon initial values of 12 routine physiologic measurements, age, and previous health status, are presented.
Abstract: This paper presents the form and validation results of APACHE II, a severity of disease classification system. APACHE II uses a point score based upon initial values of 12 routine physiologic measurements, age, and previous health status to provide a general measure of severity of disease. An increasing score (range 0 to 71) was closely correlated with the subsequent risk of hospital death for 5815 intensive care admissions from 13 hospitals. This relationship was also found for many common diseases. When APACHE II scores are combined with an accurate description of disease, they can prognostically stratify acutely ill patients and assist investigators comparing the success of new or differing forms of therapy. This scoring index can be used to evaluate the use of hospital resources and compare the efficacy of intensive care in different hospitals or over time.

14,583 citations

Journal ArticleDOI
TL;DR: The form and validation results of APACHE II, a severity of disease classification system, are presented, showing an increasing score was closely correlated with the subsequent risk of hospital death for 5815 intensive care admissions from 13 hospitals.
Abstract: This paper presents the form and validation results of APACHE II, a severity of disease classification system. APACHE II uses a point score based upon initial values of 12 routine physiologic measurements, age, and previous health status to provide a general measure of severity of disease. An increasing score (range 0 to 71) was closely correlated with the subsequent risk of hospital death for 5815 intensive care admissions from 13 hospitals. This relationship was also found for many common diseases.When APACHE II scores are combined with an accurate description of disease, they can prognostically stratify acutely ill patients and assist investigators comparing the success of new or differing forms of therapy. This scoring index can be used to evaluate the use of hospital resources and compare the efficacy of intensive care in different hospitals or over time.

5,266 citations


"Benzodiazepine versus nonbenzodiaze..." refers background in this paper

  • ...On average, patients were older (mean age = 59 yr), severely ill (average Acute Physiology and Chronic Health Evaluation II score = 21), and mostly (75%) medical (28)....

    [...]

  • ...Characteristics of Randomized Studies Evaluating the Effect of Benzodiazepine Versus Nonbenzodiazepine-Based Sedation on Clinical Outcomes Trial (n) Trial Design Patient Population (Severity of Illness) Interventiona Method and Frequency of Sedation Assessment/Sedation Goal Daily Sedation Interruption Ventilator Weaning Protocol Used Daily Delirium Assessment Defined Outcome Data Available Carson et al (2) (132) Randomized open-label, multicenter Medical (22)b Lorazepam by intermittent bolus Ramsay every 2 hr Yes Yes No ICU LOS, ventilator days, hospital mortality Propofol Ramsay of 2–3 Jakob et al (27) (500)c Randomized double-blind, double-dummy multinational, multicenter Mixedd (45)e Midazolam RASS every 2 hr Yes Not stated Nof ICU LOS, ventilator days, 45-d mortality Dexmedetomidine RASS of 0 to –3 Pandharipande et al (4) (103) Randomized, double-blind, multicenter Mixedd (28)b Lorazepam RASS (frequency not stated) No No Yes with CAM-ICU ICU LOS, ventilator days, 28-d mortality, delirium Dexmedetomidine RASS target determined by team Riker et al (5) (366) Randomized, double-blind, multicenter Mixedd (19)b Midazolam RASS every 4 hr Yes Not stated Yes with CAM-ICU ICU LOS, ventilator days, delirium, 30-d mortality Dexmedetomidine RASS of –2 to +1 Ruokonen et al (6) (67) Randomized, double-blind, double-dummy, multicenter Mixedd (2.5)g Midazolam RASS (frequency not stated) Yes Not stated Yes, but no details provided ICU LOS Dexmedetomidine RASS target determined by team Weinbroum et al (3) (67) Randomized, unblinded Mixedd (17)b Midazolam Propofol Unique scoring system developed for study (frequency of assessment not provided) No No No ICU LOS Target light sedation LOS = length of stay, RASS = Richmond Agitation-Sedation Scale, CAM-ICU = Confusion Assessment Method for the ICU. aContinuous IV infusion unless otherwise stated. bAverage Acute Physiology and Chronic Health Evaluation II score across all study groups. cBased on intention to treat. dMixed = mixed medical/surgical population. eAverage Simplified Acute Physiology Score-2 across all study groups. fDelirium assessment with CAM-ICU 48 hr after sedation discontinuance. gMean organ failure....

    [...]

  • ...Trial (n) Trial Design Patient Population (Severity of Illness) Interventiona Method and Frequency of Sedation Assessment/Sedation Goal Daily Sedation Interruption Ventilator Weaning Protocol Used Daily Delirium Assessment Defined Outcome Data Available Carson et al (2) (132) Randomized open-label, multicenter Medical (22)b Lorazepam by intermittent bolus Ramsay every 2 hr Yes Yes No ICU LOS, ventilator days, hospital mortality Propofol Ramsay of 2–3 Jakob et al (27) (500)c Randomized double-blind, double-dummy multinational, multicenter Mixedd (45)e Midazolam RASS every 2 hr Yes Not stated Nof ICU LOS, ventilator days, 45-d mortality Dexmedetomidine RASS of 0 to –3 Pandharipande et al (4) (103) Randomized, double-blind, multicenter Mixedd (28)b Lorazepam RASS (frequency not stated) No No Yes with CAM-ICU ICU LOS, ventilator days, 28-d mortality, delirium Dexmedetomidine RASS target determined by team Riker et al (5) (366) Randomized, double-blind, multicenter Mixedd (19)b Midazolam RASS every 4 hr Yes Not stated Yes with CAM-ICU ICU LOS, ventilator days, delirium, 30-d mortality Dexmedetomidine RASS of –2 to +1 Ruokonen et al (6) (67) Randomized, double-blind, double-dummy, multicenter Mixedd (2.5)g Midazolam RASS (frequency not stated) Yes Not stated Yes, but no details provided ICU LOS Dexmedetomidine RASS target determined by team Weinbroum et al (3) (67) Randomized, unblinded Mixedd (17)b Midazolam Propofol Unique scoring system developed for study (frequency of assessment not provided) No No No ICU LOS Target light sedation LOS = length of stay, RASS = Richmond Agitation-Sedation Scale, CAM-ICU = Confusion Assessment Method for the ICU. aContinuous IV infusion unless otherwise stated. bAverage Acute Physiology and Chronic Health Evaluation II score across all study groups. cBased on intention to treat. dMixed = mixed medical/surgical population. eAverage Simplified Acute Physiology Score-2 across all study groups. fDelirium assessment with CAM-ICU 48 hr after sedation discontinuance. gMean organ failure....

    [...]

  • ...Pandharipande et al (4) (103) Randomized, double-blind, multicenter Mixedd (28)b Lorazepam RASS (frequency not stated) No No Yes with CAM-ICU ICU LOS, ventilator days, 28-d mortality, delirium Dexmedetomidine RASS target determined by team...

    [...]

Journal ArticleDOI
TL;DR: These guidelines provide a roadmap for developing integrated, evidence-based, and patient-centered protocols for preventing and treating pain, agitation, and delirium in critically ill patients.
Abstract: Objective:To revise the “Clinical Practice Guidelines for the Sustained Use of Sedatives and Analgesics in the Critically Ill Adult” published in Critical Care Medicine in 2002.Methods:The American College of Critical Care Medicine assembled a 20-person, multidisciplinary, multi-institutional task f

3,005 citations

Related Papers (5)